|
Univariate model
|
Multivariate model 1
|
Multivariate model 2
|
---|
Factor
|
OR (95%CI)
|
P value
|
OR (95%CI)
|
P value
|
OR (95%CI)
|
P value
|
---|
Age (61 ≤)
|
0.3(0.2–0.8)
|
0.0099*
|
0.4 (0.2–0.8)
|
0.06
|
0.4 (0.2–0.8)
|
0.02*
|
Sex (male)
|
1.3 (0.6–2.9)
|
0.54
|
-
|
-
|
-
|
-
|
Stage III, IV
|
0.8 (0.4–1.9)
|
0.68
|
-
|
-
|
-
|
-
|
Extranodal site (2 ≤)
|
1.0 (0.4–2.3)
|
1.00
|
-
|
-
|
-
|
-
|
LDH (> upper normal limit)
|
0.5 (0.2–1.2)
|
0.11
|
-
|
-
|
0.6 (0.3–1.4)
|
0.24
|
Performance status (2–4)
|
0.6 (0.2–1.5)
|
0.24
|
-
|
-
|
-
|
-
|
IPI (high/high intermediate)
|
0.4 (0.2–1.0)
|
0.04*
|
0.6 (0.3–1.6)
|
0.33
|
-
|
-
|
Alb (3.5 mg/dl >)
|
0.8 (0.5–1.4)
|
0.50
|
-
|
-
|
-
|
-
|
Prophylactic G-CSF +
|
1.7 (0.7–3.8)
|
0.22
|
-
|
-
|
-
|
-
|
- IPI: international prognostic index. G-CSF: granulocyte colony-stimulating factor